Accession Number: | 0000899243-20-012822 |
Date: | 2020-05-12 |
Issuer: | FULCRUM THERAPEUTICS, INC. (FULC) |
Original Submission Date: |
CADAVID DIEGO
C/O FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-12 | M | 1,860 | a | $4.83 | 68,645 | direct | ||
COMMON STOCK | 2020-05-12 | S | 1,860 | d | $18.00 | 66,785 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 4.83 | 2020-05-12 | deemed execution date | M | 1,860 (d) | 2028-07-10 | common stock 1,860 | $4.83 | 15,997 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 19, 2019. |
f2 | the shares underlying the option are scheduled to vest in equal quarterly installments from july 16, 2018 through july 15, 2022. |